0.77
0.77 (0%)
As of Feb 14, 2025
Century Therapeutics, Inc. [IPSC]
Source:
Company Overview
Century Therapeutics, Inc is a clinical-stage biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases and cancer.
| Country | United States |
| Headquarters | philadelphia, pennsylvania |
| Phone Number | 215-981-4000 |
| Industry | |
| CEO | Brent Pfeiffenberger, Pharmd, Mba |
| Website | www.centurytx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $6.6 |
| Operating Profit | $-138.1 |
| Net Income | $-126.6 |
| Net Cash | $11.9 |
Profit Ratios
| Gross Margin | $6.6 |
| Operating Margin | -2,096.5 |
| Profit as % of Revenues | -5.2% |
| Profit as % of Assets | -35.5% |
| Profit as % of Stockholder Equity | -78.4% |
Management Effectiveness
| Return on Equity | -78.4% |
| Return on Assets | -35.8% |
| Turnover Ratio | 1.9% |
| EBITA | $-138.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $353.2 |
| Total Liabilities | $191.9 |
| Operating Cash Flow | $-110.1 |
| Investing Cash Flow | $47.5 |
| Financing Cash Flow | $74.6 |
